NEU 2.81% $18.65 neuren pharmaceuticals limited

Ann: Neuren corporate presentation, 24 February 2021, page-43

  1. 1,016 Posts.
    lightbulb Created with Sketch. 85
    To be fair though this things valuation makes absolutely no sense. Since January we have the orphan designation still valued below pre-covid levels? What?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.